Lifecore Biomedical, Inc. De (LFCR) Interest & Investment Income (2010 - 2025)

Lifecore Biomedical's Interest & Investment Income history runs 16 years deep, the most recent figure standing at -$5.1 million for Q2 2025.

• In Q2 2025, Interest & Investment Income rose 57.72% year-over-year to -$5.1 million; the TTM figure through May 2025 stood at -$17.1 million (down 31.72% YoY), while the FY2025 annual figure was -$18.9 million, down 28.76% from the prior year.
• Interest & Investment Income was -$5.1 million for Q2 2025 at Lifecore Biomedical, down from $108000.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $108000.0 in Q1 2025 to a low of -$12.1 million in Q2 2024.
• Historically, Interest & Investment Income has averaged -$1.2 million across 5 years, with a median of $17000.0 in 2021.
• The sharpest annual moves came in 2024 and 2025: Interest & Investment Income tumbled 57795.24% in 2024, then surged 111.73% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at $19000.0 in 2021, then dropped by 15.79% to $16000.0 in 2022, then surged by 31.25% to $21000.0 in 2023, then decreased by 28.57% to $15000.0 in 2024, then plunged by 34253.33% to -$5.1 million in 2025.
• The last three Interest & Investment Income figures came in at -$5.1 million (Q2 2025), $108000.0 (Q1 2025), and $15000.0 (Q3 2024), per Business Quant data.